Plus people moves at Moon Rabbit and Moderna.
Hydroxychloroquine study suggesting safety risks retracted; Health official urges protesters to get tested for COVID-19; AstraZeneca to distribute 2 billion doses of potential coronavirus vaccine.
The COVID-19 pandemic has brought out the best in the healthcare marketing industry. Here’s a roundup of what various companies are doing.
This week’s Coronavirus Briefing is 979 words and will take you five minutes to read.
The network – following its IPG parent company’s footsteps – is closing all offices on June 5.
Hydroxychloroquine study finds it does not prevent COVID-19 in exposed patients; Federal government picks five promising coronavirus vaccines; Gilead could earn $7 in revenue from remdesivir.
Gilead develops easier-to-administer versions of Remdesivir; Pharma, agencies respond to George Floyd’s death; Social distancing most effective way to combat COVID-19.
Publicis CEO also called for industry-wide solidarity in light of COVID-19.
Yannick Bolloré acknowledges ‘America is in pain right now’ amid the George Floyd outcry.
26,000 nursing home residents died from COVID-19; Remdesivir modestly improves condition for some patients; Register for the MM&M Agency 100.